Clinical trial
Randomized, Double-Blind, Multiple-Center, Placebo-Controlled Study Comparing the Safety and Efficacy of Generic Diclofenac Epolamine to Flector® Patch in the Treatment of Acute Pain Due to Minor Ankle Sprain
NCT02324270 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-Blind, Multiple-Center, Placebo-Controlled Study Comparing the Safety and Efficacy of Generic Diclofenac Epolamine to Flector® Patch in the Treatment of Acute Pain Due to Minor Ankle Sprain
- Lead sponsor
- Actavis Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- December 31, 2014
- Enrollment
- 658 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
ankle sprain